-- Robert Preidt
WEDNESDAY, Dec. 19 (HealthDay News) -- An aging population of
adults with hepatitis C is behind an increasing demand for liver
transplantation in the United States, a new study reveals.
The findings suggest that the development of liver cancer in
baby boomers with hepatitis C is spurring the continuing increased
demand for liver transplantation, but that the demand may decrease
as these patients grow older, the study authors said.
The researchers analyzed data from the Organ Procurement and
Transplantation Network between 1995 and 2010, and found that
nearly 127,000 new candidates for first liver transplant registered
with the network during that time.
Forty-one percent of those patients had hepatitis C. People born
between 1941 and 1960 accounted for 81 percent of all new liver
transplant registrants infected with the virus, according to the
study in the December issue of the journal
"The dire projections in [hepatitis C virus] complications spurred our investigation of age-specific trends in liver transplantation demand," study lead author Dr. Scott Biggins, of the University of Colorado School of Medicine, said in a journal news release.
The investigators also found that between 2000 and 2010, rates
of new liver transplant candidates with hepatitis C and liver
cancer quadrupled in those who were born between 1941 and 1960.
"Over the coming decade, the aging of those infected with [hepatitis C virus] will challenge the transplant community to reconsider current treatment plans given the projected increase in liver transplantation demand, particularly from patients with [hepatitis C virus] and liver cancer," Biggins said.
And "many of these patients may not be healthy enough for
transplantation, and the number of liver transplants in patients
with [hepatitis C virus] may decrease," he added.
Hepatitis C virus infects more than 1 percent of Americans and
is the most common blood-borne infection and cause of liver disease
requiring transplantation in the United States, according to the
news release. Previous research shows that 10 to 20 percent of
people living with chronic infection will develop cirrhosis and up
to 5 percent will develop liver cancer.
The U.S. National Institute of Allergy and Infectious Diseases
has more about
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.